As it approaches the late February release of its full-year 2015 financial results, Care.com (NYSE:CRCM) continues to encounter a lethargic reception by the equity market. The shares are down approximately 65% since the January 2014 IPO, and aggregate public shareholder value of roughly $350 million has been destroyed in that time.
Despite some modestly encouraging trends on the expense front, the company continues to hemorrhage cash. Top line growth continues at a nice (albeit slowing) pace, but also remains unable to be translated into cash flow.
Based on a variety of factors outlined below, I believe the shares could trade as low as $4.25. By way of comparison, the market's current implied value of the business (after backing
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|